Search research articles
Contact Us
Filters
Showing results (311-320 of 524) with videos related to
Page
of 53
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 11, 2020
A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers
Paul K Paik, Rachel K Kim, Linda Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 12, 2019
Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study
Daniel Morgensztern, Benjamin Besse, Laurent Greillier, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 28, 2023
Prevalence and Therapeutic Targeting of High-Level ERBB2 Amplification in NSCLC
Igor Odintsov, Maisam Makarem, Mizuki Nishino, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 4, 2020
Clinical outcomes, local-regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab
Michael Offin, Narek Shaverdian, Andreas Rimner, et al.
The Oncologist
|
May 11, 2025
Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors
Ian Nykaza, Yonina R Murciano-Goroff, Antoine Desilets, et al.
Iscience
|
October 29, 2021
MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer
Rebecca Caeser, Christopher Hulton, Emily Costa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2022
Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity
Kathryn M Tully, Salomon Tendler, Lukas M Carter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2019
Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations
Siddhartha Devarakonda, Sumithra Sankararaman, Brett H Herzog, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 28, 2016
A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer
M Catherine Pietanza, Anya M Litvak, Anna M Varghese, et al.
Cancer Discovery
|
November 6, 2023
Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma
Zhuxuan Li, Xueqian Zhuang, Chun-Hao Pan, et al.
Page
of 53
Search research articles
Search
Showing results (311-320 of 524) with videos related to
Sort By:
Page
of 53
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 11, 2020
A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers
Paul K Paik, Rachel K Kim, Linda Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 12, 2019
Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study
Daniel Morgensztern, Benjamin Besse, Laurent Greillier, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 28, 2023
Prevalence and Therapeutic Targeting of High-Level ERBB2 Amplification in NSCLC
Igor Odintsov, Maisam Makarem, Mizuki Nishino, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 4, 2020
Clinical outcomes, local-regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab
Michael Offin, Narek Shaverdian, Andreas Rimner, et al.
The Oncologist
|
May 11, 2025
Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors
Ian Nykaza, Yonina R Murciano-Goroff, Antoine Desilets, et al.
Iscience
|
October 29, 2021
MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer
Rebecca Caeser, Christopher Hulton, Emily Costa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2022
Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity
Kathryn M Tully, Salomon Tendler, Lukas M Carter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2019
Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations
Siddhartha Devarakonda, Sumithra Sankararaman, Brett H Herzog, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 28, 2016
A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer
M Catherine Pietanza, Anya M Litvak, Anna M Varghese, et al.
Cancer Discovery
|
November 6, 2023
Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma
Zhuxuan Li, Xueqian Zhuang, Chun-Hao Pan, et al.
Page
of 53